Pathology Core
病理学核心
基本信息
- 批准号:10709234
- 负责人:
- 金额:$ 22.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-19 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:ArchivesAscitesAwardBenignBiopsy SpecimenCancer CenterClinicalClinical DataCodeColonConfidentiality of Patient InformationConsultCystDatabasesDevelopmentDiagnosisDrug resistanceEndometriumEvaluationExperimental DesignsFeasibility StudiesFemale Genital NeoplasmsFormalinFreezingFrozen SectionsFundingGenerationsGoalsGynecologicHumanImmunohistochemistryIn Situ HybridizationIndividualInstitutionInternetIntranetLaboratoriesLaboratory ResearchLinkMalignant neoplasm of ovaryMammalian OviductsMicroscopicModelingMucous MembraneMusNormal tissue morphologyOrganoidsOvarianOvarian DiseasesOvaryParaffin EmbeddingPathologicPathologistPathologyPatientsPopulation ResearchProcessResearchResearch PersonnelResearch Project GrantsResearch ProposalsResourcesSamplingSecurityServicesSlideSolid NeoplasmSourceSpecimenTechnologyTestingTissue BanksTissue EmbeddingTissue MicroarrayTissuesTumor BankTumor TissueUniversity of Texas M D Anderson Cancer Centerbiomarker identificationcareerdata accessendometriosisexperienceexperimental studynovel therapeuticspatient derived xenograft modelquality assurancetumorvirtual
项目摘要
Core C: Pathology SUMMARY/ ABSTRACT
The individual research projects comprising this Ovarian Cancer SPORE application require the procurement,
processing, and analysis of histopathological material from patients with ovarian cancer and benign ovarian
diseases. The research projects have needs for frozen and formalin-fixed, paraffin-embedded samples of
tumor and normal tissue. The research projects also need patient-derived xenograft models and organoids to
test the effects of novel drugs and define the mechanisms of drug resistance. The proposed Pathology Core
augments the already established MD Anderson Cancer Center Gynecological Tumor Bank and the P30-
sponsored MD Anderson Cancer Center Centralized Tissue Repository with supporting database and intranet
access. The Core provides for tissue acquisition by experienced gynecological pathologists to assure high-
quality tissues for the investigators participating in this SPORE as well as investigators of other SPOREs.
The goal of the Pathology Core is to provide frozen tissue, paraffin-embedded tissue, histopathological
expertise, tissue arrays, patient-derived xenografts, and organoids related to the specific needs of the research
projects comprising this SPORE proposal. To meet this goal, the following Specific Aims are proposed for this
Core. Aim 1 is to maintain a frozen and paraffin-embedded tissue repository of ovarian cancers, normal
ovaries, and benign ovarian processes (such as cysts and endometriosis). Aim 2 is to provide pathological
review for all clinical specimens utilized in the SPORE projects and to provide histopathological and
immunohistochemical technical services as necessary. Aim 3 is to create tissue microarrays, patient-derived
xenografts (PDXs), and organoid models and maintain a relational SPORE Database. This SPORE Database
will provide for a virtual tissue repository that can be shared electronically with all SPORE investigators.
核心C:病理学摘要/摘要
包括卵巢癌孢子应用的个别研究项目需要采购,
卵巢癌和卵巢良性肿瘤患者组织病理学资料的处理和分析
疾病。研究项目需要冰冻和福尔马林固定的石蜡包埋样本
肿瘤和正常组织。研究项目还需要患者衍生的异种移植模型和有机化合物来
测试新药的效果并确定耐药机制。建议的病理学核心
扩大已经建立的MD Anderson癌症中心妇科肿瘤库和P30-
赞助MD Anderson癌症中心中央组织资料库及支援资料库及内联网
进入。核心提供由经验丰富的妇科病理学家进行组织采集,以确保高度的
为参与这一孢子的调查人员以及其他孢子的调查人员提供优质组织。
病理核心的目标是提供冰冻组织、石蜡包埋组织、组织病理学
与研究的特定需求相关的专业知识、组织阵列、患者来源的异种移植物和有机物
组成这个孢子提案的项目。为实现这一目标,提出了以下具体目标
核心。目标1是维护一个冷冻和石蜡包埋的卵巢癌组织信息库,正常
卵巢和良性卵巢突起(如囊肿和子宫内膜异位症)。目标2是提供病理性的
审查所有在孢子项目中使用的临床标本,并提供组织病理学和
必要时提供免疫组织化学技术服务。目标3是创建由患者衍生的组织微阵列
异种移植物(PDX)和器官模型,并维护一个相关的孢子数据库。这个孢子数据库
将提供一个虚拟组织储存库,可与所有孢子调查人员以电子方式共享。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JINSONG LIU其他文献
JINSONG LIU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JINSONG LIU', 18)}}的其他基金
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号转导、衰老成纤维细胞和卵巢癌进展
- 批准号:
8053814 - 财政年份:2008
- 资助金额:
$ 22.6万 - 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号转导、衰老成纤维细胞和卵巢癌进展
- 批准号:
7810639 - 财政年份:2008
- 资助金额:
$ 22.6万 - 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号转导、衰老成纤维细胞和卵巢癌进展
- 批准号:
7534226 - 财政年份:2008
- 资助金额:
$ 22.6万 - 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号传导、衰老成纤维细胞和卵巢癌进展
- 批准号:
7631233 - 财政年份:2008
- 资助金额:
$ 22.6万 - 项目类别:
RAS Signaling, Senescent Fibroblasts, and Ovarian Cancer Progression
RAS 信号转导、衰老成纤维细胞和卵巢癌进展
- 批准号:
8240516 - 财政年份:2008
- 资助金额:
$ 22.6万 - 项目类别:
相似海外基金
Analyses of immune response and bacteria in cirrhotic ascites with Tm mapping method.
Tm 图谱法分析肝硬化腹水中的免疫反应和细菌。
- 批准号:
20K08305 - 财政年份:2020
- 资助金额:
$ 22.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Randomized controlled trial to elucidate "would patients be weakened if ascites removed?"
随机对照试验阐明“如果腹水被清除,患者会变得虚弱吗?”
- 批准号:
20K16567 - 财政年份:2020
- 资助金额:
$ 22.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of new immuno-cell therapy for the treatment of refractory malignant ascites and pleural effusion
开发新的免疫细胞疗法治疗难治性恶性腹水和胸腔积液
- 批准号:
19K09196 - 财政年份:2019
- 资助金额:
$ 22.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Ascites proteomics reveal the mechanism of pancreatic cancer peritoneal dissemination
腹水蛋白质组学揭示胰腺癌腹膜播散机制
- 批准号:
19K18107 - 财政年份:2019
- 资助金额:
$ 22.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Novel Therapy for gastrointestinal cancer targeting exosome in malignant ascites
一种针对恶性腹水中外泌体的胃肠癌新疗法
- 批准号:
18H02882 - 财政年份:2018
- 资助金额:
$ 22.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Peritoneal metastasis Prediction by exosome in washing ascites for gastric cancer
胃癌洗腹水中外泌体预测腹膜转移
- 批准号:
18K16321 - 财政年份:2018
- 资助金额:
$ 22.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid
无标记微流体从腹水中的非癌细胞中富集癌细胞
- 批准号:
9251748 - 财政年份:2016
- 资助金额:
$ 22.6万 - 项目类别:
Preparation of ascites purification device for cancerous ascites and establishment of portable continuous ascites purification perfusion method
癌性腹水腹水净化装置的研制及便携式连续腹水净化灌注方法的建立
- 批准号:
16K01425 - 财政年份:2016
- 资助金额:
$ 22.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid
无标记微流体从腹水中的非癌细胞中富集癌细胞
- 批准号:
9036692 - 财政年份:2016
- 资助金额:
$ 22.6万 - 项目类别:
Identifying Factors in Malignant Ascites Facilitating Gastric Adenocarcinoma Peritoneal Metastasis
确定恶性腹水促进胃腺癌腹膜转移的因素
- 批准号:
349961 - 财政年份:2015
- 资助金额:
$ 22.6万 - 项目类别:
Studentship Programs